Recently added articles from Anti-Infectives Week:
Research from University of Massachusetts provide new insights into borrelia.
Dec 28, 2009 ... "Persistence of tissue spirochetes of Borrelia burgdorferi as helices and round bodies (RBs) explains many erythema-Lyme disease symptoms. Spirochete RBs (reproductive propagules also called coccoid bodies, globular bodies, spherical bodies, granules, cysts, L-forms, sphaeroplasts, or ...
Trial Date Set for CUBICIN[R] Patent Litigation.
Dec 28, 2009 ... Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) announced that a trial date has been set for patent litigation in the U.S. District Court for the District of Delaware against Teva Parenteral Medicines, Inc. (TPM), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. alleging ...
New drug resistance study findings have been reported by E. Verkade and colleagues.
Dec 28, 2009 ... According to recent research from Netherlands, "Oxoid Brilliance ™ MRSA was evaluated for its ability to identify methicillin-resistant Staphylococcus aureus." "A well-defined collection of staphylococci was used (n = 788). After 20 h incubation, the sensitivity was 99.6% ...
Reports from L.M. Napolitano and colleagues advance knowledge in drug resistance.
Dec 28, 2009 ... "Reported infections due to methicillin-resistant Staphylococcus aureus (MRSA) are increasing. Although most of these cases are skin and skin structure infections, necrotizing pneumonias also have been reported," researchers in the United States report (see also Drug Resistance). ...
Research from Stanford University, Medical Department yields new findings on drug resistance.
Dec 28, 2009 ... According to a study from the United States, "Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection is an increasing problem in athletic populations, with outbreaks spreading among team members. Due to this elevated risk, several strategies have been adopted ...